In addition, how UCMSC inhibits Angptl4 expression in podocytes is still worthy of further study, which will make a foundation for modifying UCMSC to improve its therapeutic effect on DN in the future. This evidence concerns the gene ANGPTL4 and liver dysplastic nodule.